It was reported to be related to numerous solid tumors, and increased expression of FYN was found to play a promoting role both in cancer occurrence and progression, as well as be a mechanism of resistance to anticancer agents [28] such as breast cancer [29], and pancreatic cancer [30]. Here, FYN is linked to familial pancreatic carcinoma.